Rare Thyroid
2 products tracked · names used in filings: Rare Thyroid, Rare Thyroid Therapeutics International AB
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Mon 28 Sep 2026🇺🇸 FDA approval
FDA approves Emcitate (tiratricol), a new medicine
Rare Thyroid; NDA220963; New molecular entity, Priority review; tablet, for suspension · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Emcitate tiratricol | Approved | 2026-09-28 |
| 🇪🇺 | Emcitate tiratricol | Authorised | 2025-02-12 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.